Deferred Tax Assets, Valuation Allowance of Surgery Partners, Inc. from 31 Dec 2014 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Surgery Partners, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2014 to 31 Dec 2025.
  • Surgery Partners, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $317,900,000, a 12% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Surgery Partners, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $317,900,000 +$33,200,000 +12% 31 Dec 2025 10-K 02 Mar 2026 2025 FY
Q4 2024 $284,700,000 +$134,600,000 +90% 31 Dec 2024 10-K 02 Mar 2026 2025 FY
Q4 2023 $150,100,000 +$35,400,000 +31% 31 Dec 2023 10-K 07 Mar 2025 2024 FY
Q4 2022 $114,700,000 +$1,700,000 +1.5% 31 Dec 2022 10-K 26 Feb 2024 2023 FY
Q4 2021 $113,000,000 +$21,900,000 +24% 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q4 2020 $91,100,000 +$13,200,000 +17% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q4 2019 $77,900,000 +$27,500,000 +55% 31 Dec 2019 10-K 10 Mar 2021 2020 FY
Q4 2018 $50,400,000 +$39,368,000 +357% 31 Dec 2018 10-K 13 Mar 2020 2019 FY
Q3 2018 $11,400,000 30 Sep 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 $6,900,000 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q4 2017 $11,032,000 +$3,674,000 +50% 31 Dec 2017 10-K 15 Mar 2019 2018 FY
Q4 2016 $7,358,000 +$409,000 +5.9% 31 Dec 2016 10-K 10 Mar 2017 2016 FY
Q4 2015 $6,949,000 -$135,960,000 -95% 31 Dec 2015 10-K 10 Mar 2017 2016 FY
Q4 2014 $142,909,000 31 Dec 2014 10-K 11 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.